May 6, 2020 / 12:03 PM / 25 days ago

BRIEF-China Grand Pharmaceutical And Healthcare's Drug Got Approval For Phase II Clinical Research On Covid-19 ARDS

May 6 (Reuters) - China Grand Pharmaceutical and Healthcare Holdings Ltd:

* GROUP’S DRUG STC3141 GOT APPROVAL FOR PHASE II CLINICAL RESEARCH ON COVID-19 ARDS

* GOT APPROVAL FOR PHASE IB CLINICAL RESEARCH FOR TREATMENT OF SEPSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below